Tenofovir Disoproxil Fumarate

Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study

Reducing Vertical Transmission of Hepatitis B in Africa

Replicor Compassionate Access Program

Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease

Pharmacokinetics of Antiretroviral Drugs in Lactating Women and Breastmilk Fed Infants Under 6 Months of Age in Botswana

Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF

Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen

Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia

PK of TAF and TDF for PrEP in Pregnant and Postpartum Women

Liver Status and Presence of MASLD/MASH in Patients With Chronic Hepatitis B

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors

Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.

HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.

Use of TDF in Patients With Inactive Chronic Hepatitis B Infection

The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure

Bone Mineral Density Substudy - An Ancillary Study to MTN-003

Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus

Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients

Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in Serum